Objectives: The purpose of this study was to investigate diffuse myocardial fibrosis in
patients with systolic heart failure (SHF) and in patients with heart failure with preserved …

Objectives: This study sought to assess the presence and extent of focal and diffuse fibrosis
in heart failure in patients with preserved ejection fraction (HFpEF) compared to …

Background Increased myocardial fibrosis may play a key role in heart failure with preserved
ejection fraction (HFpEF) pathophysiology. The study aim was to evaluate the presence …

Background The aim of this study was to investigate the prognostic value of myocardial focal
fibrosis quantified by late gadolinium enhanced (LGE) magnetic resonance imaging (MRI) in …

Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

Background—Fibrosis is a common end point of many pathological processes affecting the
myocardium and may alter myocardial relaxation properties. By measuring myocardial …

Background: Although myocardial fibrosis plays an important role in the progression of heart
failure (HF), its prognostic impact still remains to be clarified. Methods and Results: A total of …

Background—Myocardial extracellular volume (ECV) accumulation is one of the key
pathophysiologic features of heart failure with preserved ejection fraction (HFpEF). Our aims …

Objectives: The purpose of this study was to investigate a noninvasive method for
quantifying diffuse myocardial fibrosis with cardiac magnetic resonance imaging (CMRI) …

Background: Myocardial fibrosis, identified by late gadolinium enhancement cardiovascular
magnetic resonance, predicts outcomes in chronic heart failure (HF). Its prognostic …